BCI
RPRX icon

Brinker Capital Investments’s Royalty Pharma RPRX Stock Holding History

Brinker Capital Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57M Buy
99,319
+83,980
+547% +$4.37M 0.04% 362
2026
Q1 		$736K Sell
15,339
-2,569
-14% -$113K 0.01% 1294
2025
Q4 		$692K Buy
17,908
+38
+0.2% +$1.45K 0.01% 1442
2025
Q3 		$630K Buy
17,870
+3,450
+24% +$125K ﹤0.01% 1450
2025
Q2 		$520K Buy
14,420
+5,231
+57% +$173K ﹤0.01% 1489
2025
Q1 		$286K Buy
+9,189
New +$291K ﹤0.01% 1651

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brinker Capital Investments's RPRX Position: Q2 2026 in Review

Brinker Capital Investments increased its Royalty Pharma (RPRX) stake by 547% in Q2 2026, buying an estimated $4.37M and bringing the position to 99,319 shares worth $5.57M. The position accounts for 0.04% of the portfolio, ranked #362.

Brinker Capital Investments first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 642 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Brinker Capital Investments held 99,319 shares of Royalty Pharma worth $5.57M as of Q2 2026.
  • Brinker Capital Investments bought 83,980 Royalty Pharma shares in Q2 2026, an estimated $4.37M.
  • Royalty Pharma made up 0.04% of Brinker Capital Investments's portfolio in Q2 2026, its #362 holding.
  • Brinker Capital Investments first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 642 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.